Literature DB >> 15599161

Management of the critically ill patient with severe acute pancreatitis.

Avery B Nathens1, J Randall Curtis, Richard J Beale, Deborah J Cook, Rui P Moreno, Jacques-Andre Romand, Shawn J Skerrett, Renee D Stapleton, Lorraine B Ware, Carl S Waldmann.   

Abstract

OBJECTIVE: Acute pancreatitis represents a spectrum of disease ranging from a mild, self-limited course requiring only brief hospitalization to a rapidly progressive, fulminant illness resulting in the multiple organ dysfunction syndrome (MODS), with or without accompanying sepsis. The goal of this consensus statement is to provide recommendations regarding the management of the critically ill patient with severe acute pancreatitis (SAP). DATA SOURCES AND METHODS: An international consensus conference was held in April 2004 to develop recommendations for the management of the critically ill patient with SAP. Evidence-based recommendations were developed by a jury of ten persons representing surgery, internal medicine, and critical care after conferring with experts and reviewing the pertinent literature to address specific questions concerning the management of patients with severe acute pancreatitis. DATA SYNTHESIS: There were a total of 23 recommendations developed to provide guidance to critical care clinicians caring for the patient with SAP. Topics addressed were as follows. 1) When should the patient admitted with acute pancreatitis be monitored in an ICU or stepdown unit? 2) Should patients with severe acute pancreatitis receive prophylactic antibiotics? 3) What is the optimal mode and timing of nutritional support for the patient with SAP? 4) What are the indications for surgery in acute pancreatitis, what is the optimal timing for intervention, and what are the roles for less invasive approaches including percutaneous drainage and laparoscopy? 5) Under what circumstances should patients with gallstone pancreatitis undergo interventions for clearance of the bile duct? 6) Is there a role for therapy targeting the inflammatory response in the patient with SAP? Some of the recommendations included a recommendation against the routine use of prophylactic systemic antibacterial or antifungal agents in patients with necrotizing pancreatitis. The jury also recommended against pancreatic debridement or drainage for sterile necrosis, limiting debridement or drainage to those with infected pancreatic necrosis and/or abscess confirmed by radiologic evidence of gas or results or fine needle aspirate. Furthermore, the jury recommended that whenever possible, operative necrosectomy and/or drainage be delayed at least 2-3 wk to allow for demarcation of the necrotic pancreas.
CONCLUSIONS: This consensus statement provides 23 different recommendations concerning the management of patients with SAP. These recommendations differ in several ways from previous recommendations because of the release of recent data concerning the management of these patients and also because of the focus on the critically ill patient. There are a number of important questions that could not be answered using an evidence-based approach, and areas in need of further research were identified.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15599161     DOI: 10.1097/01.ccm.0000148222.09869.92

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  69 in total

1.  Packing for damage control of nontraumatic intra-abdominal massive hemorrhages.

Authors:  Filippo Filicori; Salomone Di Saverio; Marco Casali; Andrea Biscardi; Franco Baldoni; Gregorio Tugnoli
Journal:  World J Surg       Date:  2010-09       Impact factor: 3.352

2.  Canadian clinical practice guidelines for invasive candidiasis in adults.

Authors:  Eric J Bow; Gerald Evans; Jeff Fuller; Michel Laverdière; Coleman Rotstein; Robert Rennie; Stephen D Shafran; Don Sheppard; Sylvie Carle; Peter Phillips; Donald C Vinh
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

3.  Reply to: draining sterile fluid collections in acute pancreatitis? Primum non nocere!

Authors:  Enver Zerem
Journal:  Surg Endosc       Date:  2011-03       Impact factor: 4.584

4.  Elevated serum neutrophil gelatinase-associated lipocalin is an early predictor of severity and outcome in acute pancreatitis.

Authors:  Subhankar Chakraborty; Sukhwinder Kaur; Venkata Muddana; Neil Sharma; Uwe A Wittel; Georgios I Papachristou; David Whitcomb; Randall E Brand; Surinder K Batra
Journal:  Am J Gastroenterol       Date:  2010-02-23       Impact factor: 10.864

Review 5.  Acute pancreatitis.

Authors:  Andrew Kingsnorth; Derek O'Reilly
Journal:  BMJ       Date:  2006-05-06

6.  Evidence-based treatment of acute pancreatitis: antibiotic prophylaxis in necrotizing pancreatitis.

Authors:  Marc G H Besselink; Hjalmar C van Santvoort; Erik Buskens; Hein G Gooszen
Journal:  Ann Surg       Date:  2006-10       Impact factor: 12.969

7.  As good as it gets: the study of prophylactic antibiotics in severe acute pancreatitis.

Authors:  Thomas J Howard
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969

8.  Japanese severity score for acute pancreatitis well predicts in-hospital mortality: a nationwide survey of 17,901 cases.

Authors:  Tsuyoshi Hamada; Hideo Yasunaga; Yousuke Nakai; Hiroyuki Isayama; Hiromasa Horiguchi; Kiyohide Fushimi; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2013-02-19       Impact factor: 7.527

9.  Impact of alanyl-glutamine dipeptide on severe acute pancreatitis in early stage.

Authors:  Ping Xue; Li-Hui Deng; Qing Xia; Zhao-Da Zhang; Wei-Ming Hu; Xiao-Nan Yang; Bing Song; Zong-Wen Huang
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

Review 10.  Severe acute pancreatitis: pathogenetic aspects and prognostic factors.

Authors:  Ibrahim-A Al Mofleh
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.